Related Experiment Videos
Primary malignant neoplasms associated with chronic lymphocytic leukemia
Tumori
|August 31, 1980
Summary
Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing a second primary cancer, particularly head and neck or breast cancer. This increased cancer risk may stem from immune deficiencies associated with CLL.
Area of Science:
- Oncology
- Hematology
- Immunology
Background:
- An increasing number of leukemia cases are being reported with secondary primary malignant lesions.
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by immune dysfunction.
Purpose of the Study:
- To investigate the incidence of second primary neoplasms in patients diagnosed with chronic lymphocytic leukemia (CLL).
- To explore potential etiological factors contributing to secondary malignancies in CLL patients.
Main Methods:
- Retrospective analysis of 82 consecutive chronic lymphocytic leukemia (CLL) cases admitted between 1962 and 1978.
- Documentation of concurrent or subsequent diagnoses of additional primary neoplasms.
Main Results:
- 19.5% of CLL patients (16 out of 82) developed a second primary neoplasm.
- Head and neck carcinomas (5 cases) and breast cancer (3 cases) were the most common secondary malignancies.
- No correlation was found between alkylating agent treatment and the incidence of second primary neoplasms.
Conclusions:
- Patients with chronic lymphocytic leukemia (CLL) exhibit a predisposition to developing subsequent cancers.
- Defective cellular and humoral immunity in CLL may play a role in the etiology of secondary malignancies.
- Treatment with alkylating agents does not appear to correlate with an increased risk of second primary neoplasms in CLL patients.